BDR Pharma launches generic most cancers drug in India


Drug agency BDR Prescribed drugs on Tuesday mentioned it has launched generic Cabozantinib, used for the therapy of assorted sorts of cancer, and can deliver the product in India within the subsequent few days.

Cabozantinib is used for the therapy of metastatic medullary thyroid most cancers, superior renal cell carcinoma and hepatocellular carcinoma, BDR Pharma mentioned in a press release.

“Guaranteeing that each one our sufferers have entry to quality-produced, world-class therapy at an inexpensive charge was the primary motive for launching the drug in India,” BDR Prescribed drugs, Enterprise Improvement – Director, Raheel Shah mentioned.

The corporate, nonetheless, didn’t give any particulars about the price of the drug.

Cabozantinib is prescribed for treating sufferers with progressive, metastatic medullary thyroid most cancers and as a second-line therapy for renal cell carcinoma aside from treating hepatocellular carcinoma, BDR Pharma mentioned.

The drug is accessible within the strengths of 20 mg, 40 mg and 60 mg, it added.

Source link


Please enter your comment!
Please enter your name here